0.5016

2.39% -0.0123

After Hours: .51 0.0084 +1.67%

Biora Therapeutics Inc (BIOR)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Biora Therapeutics Inc stock is traded at $0.5016, with a volume of 134.33K. It is down -2.39% in the last 24 hours and down -28.02% over the past month. Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Previous Close:

$0.5139

Open:

$0.52

24h Volume:

134.33K

Relative Volume:

0.64

Market Cap:

$18.60M

Revenue:

$98,000

Net Income/Loss:

$-122.42M

P/E Ratio:

-0.092

EPS:

-5.45

Net Cash Flow:

$-45.88M

1W Performance:

-11.66%

1M Performance:

-28.02%

6M Performance:

-54.40%

1Y Performance:

-76.88%

1-Day Range:

$0.5008

$0.534

1-Week Range:

$0.4921

$0.5798

52-Week Range:

$0.475

$2.7129

Biora Therapeutics Inc Stock (BIOR) Company Profile

Name

Biora Therapeutics Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

855-293-2639

Address

4330 LA JOLLA VILLAGE DRIVE, SAN DIEGO

Employee

Twitter

Next Earnings Date

2024-08-12

Latest SEC Filings

BIOR's Discussions on Twitter

Biora Therapeutics Inc Stock (BIOR) Latest News

08:04 AM

Biora Therapeutics Announces Award-Winning Abstract to be - GlobeNewswire

08:04 AM

08:00 AM

Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024 - StockTitan

08:00 AM

Sep 23, 2024

Biora Therapeutics Inc’s Market Journey: Closing Weak at 0.59, Down -9.63 - The Dwinnex

Sep 23, 2024

Biora Therapeutics Inc Inc. (BIOR) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Sep 23, 2024

Sep 13, 2024

A History of Outperforming Analyst Forecasts and Beating the Odds: Biora Therapeutics Inc (BIOR) - SETE News

Sep 02, 2024

Aug 28, 2024

Biora Therapeutics Announces Positive Nasdaq Listing Decision - GlobeNewswire

Aug 28, 2024

Biora Therapeutics Announces Positive Nasdaq Listing Decision - StockTitan

Aug 28, 2024

Aug 26, 2024

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Aug 26, 2024

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - The Bakersfield Californian

Aug 26, 2024

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Aug 26, 2024

Aug 23, 2024

Biora Therapeutics secures new financial agreements - Investing.com India

Aug 23, 2024

Aug 22, 2024

Biora Therapeutics secures new financial agreements - Investing.com

Aug 22, 2024

Aug 15, 2024

BIOR: Second Quarter Results - Yahoo Finance

Aug 15, 2024

Biora Therapeutics, Inc. (NASDAQ:BIOR) Forecasted to Post Q3 2024 Earnings of ($0.42) Per Share - Defense World

Aug 15, 2024

Aug 14, 2024

BIOR’s Stock Woes: Down -20.37% in 6 Months, Down -20.37% in Just 5 Days - The InvestChronicle

Aug 14, 2024

Biora Therapeutics Second Quarter 2024 Earnings: EPS: US$0.18 (vs US$1.47 loss in 2Q 2023) - Yahoo Finance

Aug 14, 2024

Biora Therapeutics (NASDAQ:BIOR) Receives “Buy” Rating from HC Wainwright - Defense World

Aug 14, 2024

Aug 13, 2024

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 13, 2024

Biora Therapeutics maintains stock target after strong Q2 results By Investing.com - Investing.com UK

Aug 13, 2024

Earnings call: Biora Therapeutics reports progress on BT-600 and BioJet platforms - Investing.com

Aug 13, 2024

Earnings call: Biora Therapeutics reports progress on BT-600 and BioJet platforms - Investing.com Canada

Aug 13, 2024